9.20
-0.06
(-0.65%)
At close: April 17 at 4:00:01 PM EDT
9.35
+0.15
+(1.63%)
After hours: April 17 at 7:24:07 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
135,157
135,157
91,370
53,905
200,577
Operating Expense
289,718
289,718
282,406
185,462
128,602
Operating Income
-154,561
-154,561
-191,036
-131,557
71,975
Net Non Operating Interest Income Expense
25,816
25,816
31,014
6,349
42
Other Income Expense
-185
-185
-458
-397
-96
Pretax Income
-128,930
-128,930
-160,480
-125,605
71,921
Tax Provision
-6,620
-6,620
-13,452
-8,656
4,946
Net Income Common Stockholders
-122,310
-122,310
-147,028
-116,949
66,975
Diluted NI Available to Com Stockholders
-122,310
-122,310
-147,028
-116,949
66,975
Basic EPS
-2.46
-2.27
-2.76
-2.47
1.51
Diluted EPS
-2.46
-2.27
-2.76
-2.47
1.38
Basic Average Shares
53,735.75
53,772
53,216
47,369
44,228
Diluted Average Shares
53,735.75
53,772
53,216
47,369
48,464
Total Operating Income as Reported
-154,561
-154,561
-191,036
-131,557
71,975
Total Expenses
289,718
289,718
282,406
185,462
128,602
Net Income from Continuing & Discontinued Operation
-122,310
-122,310
-147,028
-116,949
66,975
Normalized Income
-122,134.50
-122,134.50
-146,608.39
-116,579.36
66,975
Interest Income
25,816
25,816
31,014
6,349
42
Net Interest Income
25,816
25,816
31,014
6,349
42
EBIT
-154,561
-154,561
-191,036
-131,557
71,975
EBITDA
-153,668
-153,668
-190,108
-130,813
73,090
Reconciled Depreciation
893
893
928
744
1,115
Net Income from Continuing Operation Net Minority Interest
-122,310
-122,310
-147,028
-116,949
66,975
Total Unusual Items Excluding Goodwill
-185
-185
-458
-397
--
Total Unusual Items
-185
-185
-458
-397
--
Normalized EBITDA
-153,483
-153,483
-189,650
-130,416
73,090
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-9.50
-9.50
-38.39
-27.36
--
12/31/2021 - 12/18/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANAB AnaptysBio, Inc.
20.55
+7.82%
DNLI Denali Therapeutics Inc.
12.74
+1.51%
CGEM Cullinan Therapeutics, Inc.
7.89
+3.68%
SYRE Spyre Therapeutics, Inc.
12.67
+2.01%
DYN Dyne Therapeutics, Inc.
8.17
+4.34%
SWTX SpringWorks Therapeutics, Inc.
37.92
+0.48%
EWTX Edgewise Therapeutics, Inc.
13.45
+3.22%
XNCR Xencor, Inc.
9.70
+1.89%
IDYA IDEAYA Biosciences, Inc.
17.08
+5.56%
AKRO Akero Therapeutics, Inc.
37.63
+0.51%